Biomedical Engineering Reference
In-Depth Information
44. Princiotta, M.F., Finzi, D., Qian, S.B., Gibbs, J., Schuchmann, S., Buttgereit, F., Bennink,
J.R., Yewdell, J.W.: Quantitating protein synthesis, degradation, and endogenous antigen
processing. Immunity 18 (3), 343-354 (2003)
45. Pudney, V.A., Leese, A.M., Rickinson, A.B., Hislop, A.D.: Cd8+ immunodominance among
epstein-barr virus lytic cycle antigens directly reflects the efficiency of antigen presentation in
lytically infected cells. J. Exp. Med. 201 (3), 349-360 (2005)
46. Rehermann, B., Nascimbeni, M.: Immunology of hepatitis b virus and hepatitis c virus
infection. Nat. Rev. Immunol. 5 (3), 215-229 (2005)
47. Robinson, J., Waller, M.J., Parham, P., de Groot, N., Bontrop, R., Kennedy, L.J., Stoehr,
P., Marsh, S.G.: Imgt/hla and imgt/mhc: Sequence databases for the study of the major
histocompatibility complex. Nucleic Acids Res. 31 (1), 311-314 (2003)
48. Rock, K.L., York, I.A., Saric, T., Goldberg, A.L.: Protein degradation and the generation of
mhc class i-presented peptides. Adv. Immunol. 80 , 1-70 (2002)
49. Sirma, H., Weil, R., Rosmorduc, O., Urban, S., Israel, A., Kremsdorf, D., Brechot, C.:
Cytosol is the prime compartment of hepatitis b virus x protein where it colocalizes with the
proteasome. Oncogene 16 (16), 2051-2063 (1998)
50. Sykulev, Y., Cohen, R.J., Eisen, H.N.: The law of mass action governs antigen-stimulated
cytolytic activity of cd8+ cytotoxic t lymphocytes. Proc. Natl. Acad. Sci. USA 92 (26), 11990-
11992 (1995)
51. Tanaka, K., Tsurumi, C.: The 26s proteasome: Subunits and functions. Mol. Biol. Rep. 24 (1-2),
3-11 (1997)
52. Untersuchungen uber die chemischen Affinitaten. Abhandlungen aus den Jahren 1864 1867
1879. Ostwald's Klassiker der exakten Wissenschaften nr. 104. 1899 Leipzig: W. Engel-
mann. 182. Guldberg, C.M.
53. van Rompay, K.K.A., Dailey, P.J., Tarara, R.P., Canfield, D.R., Aguirre, N.L., Cherrington,
J.M., Lamy, P.D., Bischofberger, N., Pedersen, N.C., Marthas, M.L.: Early short-term 9-[2-(r)-
(phosphonomethoxy) propyl] adenine treatment favorably alters the subsequent disease course
in simian immunodeficiency virus-infected newborn rhesus macaques.
J. Virol. 73 (4), 2947
(1999)
54. Vider-Shalit, T., Louzoun, Y.: Mhc-i prediction using a combination of t cell epitopes and
mhc-i binding peptides. J. Immunol. Meth. 374 (1-2), 43-46 (2010)
55. Vider-Shalit, T., Fishbain, V., Raffaeli, S., Louzoun, Y.: Phase-dependent immune evasion of
herpesviruses. J. Virol. 81 (17), 9536-9545 (2007)
56. Vider-Shalit, T., Almani, M., Sarid, R., Louzoun, Y.: The hiv hide and seek game: An
immunogenomic analysis of the hiv epitope repertoire. AIDS 23 (11), 1311-1318 (2009)
57. Vider-Shalit, T., Sarid, R., Maman, K., Tsaban, L., Levi, R., Louzoun, Y.: Viruses selectively
mutate their cd8+ t-cell epitopes-a large-scale immunomic analysis.
Bioinformatics 25 (12),
i39-44 (2009)
58. (WHO), W.H.O. http://www.who.int/mediacentre/factsheets/fs204/en/ .
Search WWH ::




Custom Search